Plasmodium falciparum cGMP-Dependent Protein Kinase – A Novel Chemotherapeutic Target
The primary effector of cGMP signaling in Plasmodium is the cGMP-dependent protein kinase (PKG). Work in human-infective Plasmodium falciparum and rodent-infective Plasmodium berghei has provided biological validation of P. falciparum PKG (PfPKG) as a drug target for treating and/or protecting again...
Main Authors: | David Rotella, John Siekierka, Purnima Bhanot |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2020.610408/full |
Similar Items
-
β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes
by: Sophie Schobesberger, et al.
Published: (2020-03-01) -
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
by: Jens Schlossmann, et al.
Published: (2013-02-01) -
Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G
by: Pilar Monfort, et al.
Published: (2004-02-01) -
Redox regulation of cGMP-dependent protein kinase Iα in the cardiovascular system
by: Oleksandra ePrysyazhna, et al.
Published: (2015-07-01) -
Investigations into the role of cGMP in mediating the effects of extracellular nucleotides on root hair growth in Arabidopsis thaliana
by: Steere, Barbara A.
Published: (2010)